Screener
Fulgent Genetics, Inc. FLGT Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
FAQ
- What is Fulgent Genetics, Inc.'s debt-to-equity?
- Fulgent Genetics, Inc. (FLGT) reported debt-to-equity of 0× in Q1 2026.
- How has Fulgent Genetics, Inc.'s debt-to-equity changed year-over-year?
- Fulgent Genetics, Inc.'s debt-to-equity increased by 50.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Fulgent Genetics, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s debt-to-equity has grown at a 27.2% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Fulgent Genetics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude